Batch checker
Check a Apple Formulations Pvt. Ltd batch number
37 batches by Apple Formulations Pvt. Ltd have been declared Not of Standard Quality in CDSCO or state-lab alerts. Type your batch number to check it, or scan the full list below. Full manufacturer record
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin Metronidazole and Simethicone Suspension | OXG2501Mfg 2025-09 · Exp 2027-08 | Content of Metronidazole (45.68%)Other | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Glimepiride Tablets IP 1mg | GTA-2501Mfg 2025-01 · Exp 2027-01 | The sample does not conform to standard quality in respect of the test for ?Description? performed.Description | SDTL, Tripura, AgartalaState lab | Jul 2026 |
| Sucralfate & Oxetacaine Suspension | SCI-2508Mfg 2025-12 · Exp 2027-11 | ContentOther | DTL, Madurai-19State lab | Jun 2026 |
| Cetirizine Syrup IP | CIZ-2604Mfg 2026-03 · Exp 2028-02 | pHpH | SDTL, PunjabState lab | Jun 2026 |
| Levocetrizine Dihydrochloride Tablets IP) | LEE-2501Mfg 2025-06 · Exp 2027-05 | The sample does not conform to standard in respect of the test for Description performed.Description | SDTL,Govt. of Tripura, AgartalaState lab | May 2026 |
| Levosalbutamol, Ambroxol Hydrochloride & Guaiphenesin Syrup (Ambroflex-LS Syrup ) | AFG-2502Mfg 2025-05 · Exp 2027-04 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Dec 2025 |
| Dextromethorphan Hydrobromide, Chlorpheniramine Maleate, Phenylephrine Hydrochloride Syrup(Caredex Junior ) | CXR-2502Mfg 2025-06 · Exp 2027-05 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Dec 2025 |
| Ambroxol Hydrochloride. Levosalbutamol Sulphate and Guaiphenesin syrup (Brokuff LS Junior Syrup ) | BKJ-2503Mfg 2025-04 · Exp 2027-03 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Dec 2025 |
| Sucralfate & Oxetacaine Suspension | SCO-2503Mfg 2025-06 · Exp 2027-05 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Azithromycin Tablets IP 500 mg. | AYC-2407Mfg 2024-01 · Exp 2025-12 | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Azithromycin.Dissolution | RDTL, GuwahatiCDSCO lab | Nov 2025 |
| Ambroxol Hydrochloride 15mg, Terbutaline Sulphate 1.25 mg, Guaiphenesin 50 mg, Menthol 0.5 mg (NUREX-AP ) | NRA-2403Mfg 2024-12 · Exp 2026-11 | Assay of Ambroxol HCl (81.53%) & Terbutaline Sulphate (74.40 %)Assay | DTL Baddi H.PState lab | Oct 2025 |
| Azithromycin Tablets IP 500 mg. | AYC-2407Mfg 2024-01 · Exp 2025-12 | Dissolution of AzithromycinDissolution | RDTL GuwahatiCDSCO lab | Jun 2025 |
| Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D-Pantothenate Syrup (B-Complex Syrup) | BOB-2440Mfg 2024-06 · Exp 2025-11 | Assay of Vitamin B12Assay | CDL, KolkataCDSCO lab | Mar 2025 |
| Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D-Pantothenate Syrup (B-Complex Syrup) | BOB-2451Mfg 2024-06 · Exp 2025-11 | Total aerobic viable count under Microbial limit testMicrobial limits | CDL, KolkataCDSCO lab | Mar 2025 |
| Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D- Pantothenate Syrup (B- Complex Syrup), | BOB-2423Mfg 2024-06 · Exp 2025-11 | Assay of Calcium D-PantothenateAssay | CDL KolkataCDSCO lab | Feb 2025 |
| Sucnol-O Suspension | SCI-2305Mfg 2023-11 · Exp 2025-10 | Sample does not conform to Label Claim with respect to the content of OxetacaineLabelling | DTL MaduraiState lab | Jan 2025 |
| GLIMEPIRIDE TABLETS I.P. 1 mg. | GLT-2301Mfg 2023-01 · Exp 2024-12 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2024 |
| GLIMEPIRIDE TABLETS I.P. 1 mg. | GLT-2301Mfg 2023-01 · Exp 2024-12 | DissolutionDissolution | RDTL GuwahatiState lab | Nov 2023 |
| Rabeprazole Sodium (Enteric Coated) and Domperidone (Sustained Release) Capsules (20 mg/30 mg) | RPE-2258Mfg 2022-07 · Exp 2024-06 | Assay of Rabeprazole SodiumAssay | RDTL ChandigarhCDSCO lab | Jul 2023 |
| Glimkar-4 (Glimepiride Tablets 4 mg) | GKR-2210Mfg 2022-04 · Exp 2024-03 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2023 |
| Levocetirizine Dihydrochloride Syrup., 30ml | LZR-2202Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Feb 2023 |
| Levocetirizine Dihydrochloride Syrup., 30ml | LZR-2204Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Feb 2023 |
| Levocetirizine Dihydrochloride Syrup | LZR-2203Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Feb 2023 |
| Zinc Sulphate Oral Solution I.P., 100ml | ZCH-2207Mfg 2022-01 · Exp 2023-12 | Weight per mlWeight | RDTL GuwahatiState lab | Jan 2023 |
| Zinc Sulphate Oral Solution I.P., 100 ml | ZCH-2209Mfg 2022-01 · Exp 2023-12 | Weight per mlWeight | RDTL GuwahatiState lab | Jan 2023 |
| Levocetirizine Dihydrochloride Syrup 30 ml | LZR-2209Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Jan 2023 |
| Levocetirizine Dihydrochloride Syrup 30 ml | LZR-2207Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Jan 2023 |
| Levocetirizine Dihydrochloride Syrup 30 ml | LZR-2211Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Jan 2023 |
| Levocetirizine Dihydrochloride Syrup, 30ml | LZR-2204Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Dec 2022 |
| Levocetirizine Dihydrochloride Syrup | LZR-2204Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Dec 2022 |
| Levocetirizine Dihydrochloride Syrup | LZR-2208Mfg 2022-01 · Exp 2023-12 | ?pH?pH | RDTL GuwahatiState lab | Dec 2022 |
| Levocetirizine Dihydrochloride Syrup. 30 ml | LZR-2202Mfg 2022-01 · Exp 2023-12 | ?pH?pH | RDTL GuwahatiState lab | Nov 2022 |
| Levocetirizine Dihydrochloride Syrup (30 ml) | LZR-2207Mfg 2022-01 · Exp 2023-12 | ?pH?pH | RDTL GuwahatiState lab | Nov 2022 |
| Levocetirizine Dihydrochloride Syrup | LZR-2202Mfg 2022-01 · Exp 2023-12 | pHpH | RDTL GuwahatiState lab | Sep 2022 |
| Azithromycin Oral Suspension IP 200 mg/ 5 ml | AYA-2101Mfg 2021-01 · Exp 2022-12 | Assay/content of Anhydrous AzithromycinAssay | RDTL GuwahatiState lab | Sep 2022 |
| Levocetirizine Dihydrochloride Tablets IP 5 mg | LCL-2105Mfg 2021-07 · Exp 2023-06 | DissolutionDissolution | RDTL GuwahatiState lab | Jul 2022 |
| Paracetamol Paediatric oral Suspension IP (Parawin ?DS Suspension) | PWS-1905Mfg 2019-12 · Exp 2021-11 | Related SubstancesRelated substances | RDTL ChandigarhCDSCO lab | Nov 2020 |
Data: CDSCO NSQ portal, Jan 2019, Jul 2026. Absence from the list is not proof of quality.